Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy

Objective. To evaluate the efficacy of autologous cytokine-induced killer (CIK) cells in patients with renal cell carcinoma (RCC). Methods. 20 patients diagnosed with TNM stage I or II RCC were randomly divided into two groups, a CIK cell treatment group and a control group. The endpoint was progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yajing, Wang, Jin, Wang, Yao, Lu, Xue-Chun, Fan, Hui, Liu, Yang, Zhang, Yan, Feng, Kai-Chao, Zhang, Wen-Ying, Chen, Mei-Xia, Fu, Xiaobing, Han, Wei-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872096/
https://www.ncbi.nlm.nih.gov/pubmed/24382970
http://dx.doi.org/10.1155/2013/195691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872096/
https://www.ncbi.nlm.nih.gov/pubmed/24382970
http://dx.doi.org/10.1155/2013/195691

Ejemplares similares